NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|7019519|ref|NP_037403|]
View 

proSAAS preproprotein [Homo sapiens]

Protein Classification

ProSAAS domain-containing protein( domain architecture ID 10537956)

ProSAAS domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
ProSAAS pfam07259
ProSAAS precursor; This family consists of several mammalian proSAAS precursor proteins. ...
34-260 1.82e-29

ProSAAS precursor; This family consists of several mammalian proSAAS precursor proteins. ProSAAS mRNA is expressed primarily in brain and other neuroendocrine tissues (pituitary, adrenal, pancreas); within brain, the mRNA is broadly distributed among neurons. ProSAAS is thought to be an endogenous inhibitor of prohormone convertase 1 may function as a neuropeptide. N-terminal fragments of proSAAS in intracellular Pick Bodies (PBs) may cause a functional disturbance of neurons in Pick's disease.


:

Pssm-ID: 462126  Cd Length: 273  Bit Score: 112.01  E-value: 1.82e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519     34 ARPVKEPRGLSAASPpLAETGAPRRFRRSVPRGEAAGA-----------------------VQELARALAHLLEAERQEr 90
Cdd:pfam07259   1 AKPLKAARGLGAAGL-DAEVGGSRRFRRELPDGLPYEGqmmsyppsesgqnellyppelwrGQGLAQALQQLVEAERRR- 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519     91 araeaqeaeDQQARVLAQLLRVWGAPRNSDPALGLDDD-PDAPAAQLARALLRARLDPAALAAQLV----------PAPV 159
Cdd:pfam07259  79 ---------EQEAAYLAQLLRLWSEPQGLRGGEEDPGDfQGPYPDYDDTELGLRMDDPQAPAPQLAqallnryrqdPAAL 149
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519    160 PAAALRPRPPVYDDGPAGPDAEEAGDETPDVDPELLRYLLGRILAGSADSEGVAAPRRLRR-----AADHDVGSELPPEG 234
Cdd:pfam07259 150 AAQLLPPRPPVYDDLPTGRQAEDAGDETPDVDPELLRYLVGRVLSGSAEAEPQPEASAPPPrrlrrSLDQNPPPPVPSEE 229
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....
gi 7019519    235 VLGALLRVKRL------------------ETPAPQVPARRLLPP 260
Cdd:pfam07259 230 VSGALLRVKRLgdleglqrmkridtdlqpETYDPQAPARRLLPY 273
 
Name Accession Description Interval E-value
ProSAAS pfam07259
ProSAAS precursor; This family consists of several mammalian proSAAS precursor proteins. ...
34-260 1.82e-29

ProSAAS precursor; This family consists of several mammalian proSAAS precursor proteins. ProSAAS mRNA is expressed primarily in brain and other neuroendocrine tissues (pituitary, adrenal, pancreas); within brain, the mRNA is broadly distributed among neurons. ProSAAS is thought to be an endogenous inhibitor of prohormone convertase 1 may function as a neuropeptide. N-terminal fragments of proSAAS in intracellular Pick Bodies (PBs) may cause a functional disturbance of neurons in Pick's disease.


Pssm-ID: 462126  Cd Length: 273  Bit Score: 112.01  E-value: 1.82e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519     34 ARPVKEPRGLSAASPpLAETGAPRRFRRSVPRGEAAGA-----------------------VQELARALAHLLEAERQEr 90
Cdd:pfam07259   1 AKPLKAARGLGAAGL-DAEVGGSRRFRRELPDGLPYEGqmmsyppsesgqnellyppelwrGQGLAQALQQLVEAERRR- 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519     91 araeaqeaeDQQARVLAQLLRVWGAPRNSDPALGLDDD-PDAPAAQLARALLRARLDPAALAAQLV----------PAPV 159
Cdd:pfam07259  79 ---------EQEAAYLAQLLRLWSEPQGLRGGEEDPGDfQGPYPDYDDTELGLRMDDPQAPAPQLAqallnryrqdPAAL 149
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519    160 PAAALRPRPPVYDDGPAGPDAEEAGDETPDVDPELLRYLLGRILAGSADSEGVAAPRRLRR-----AADHDVGSELPPEG 234
Cdd:pfam07259 150 AAQLLPPRPPVYDDLPTGRQAEDAGDETPDVDPELLRYLVGRVLSGSAEAEPQPEASAPPPrrlrrSLDQNPPPPVPSEE 229
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....
gi 7019519    235 VLGALLRVKRL------------------ETPAPQVPARRLLPP 260
Cdd:pfam07259 230 VSGALLRVKRLgdleglqrmkridtdlqpETYDPQAPARRLLPY 273
 
Name Accession Description Interval E-value
ProSAAS pfam07259
ProSAAS precursor; This family consists of several mammalian proSAAS precursor proteins. ...
34-260 1.82e-29

ProSAAS precursor; This family consists of several mammalian proSAAS precursor proteins. ProSAAS mRNA is expressed primarily in brain and other neuroendocrine tissues (pituitary, adrenal, pancreas); within brain, the mRNA is broadly distributed among neurons. ProSAAS is thought to be an endogenous inhibitor of prohormone convertase 1 may function as a neuropeptide. N-terminal fragments of proSAAS in intracellular Pick Bodies (PBs) may cause a functional disturbance of neurons in Pick's disease.


Pssm-ID: 462126  Cd Length: 273  Bit Score: 112.01  E-value: 1.82e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519     34 ARPVKEPRGLSAASPpLAETGAPRRFRRSVPRGEAAGA-----------------------VQELARALAHLLEAERQEr 90
Cdd:pfam07259   1 AKPLKAARGLGAAGL-DAEVGGSRRFRRELPDGLPYEGqmmsyppsesgqnellyppelwrGQGLAQALQQLVEAERRR- 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519     91 araeaqeaeDQQARVLAQLLRVWGAPRNSDPALGLDDD-PDAPAAQLARALLRARLDPAALAAQLV----------PAPV 159
Cdd:pfam07259  79 ---------EQEAAYLAQLLRLWSEPQGLRGGEEDPGDfQGPYPDYDDTELGLRMDDPQAPAPQLAqallnryrqdPAAL 149
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 7019519    160 PAAALRPRPPVYDDGPAGPDAEEAGDETPDVDPELLRYLLGRILAGSADSEGVAAPRRLRR-----AADHDVGSELPPEG 234
Cdd:pfam07259 150 AAQLLPPRPPVYDDLPTGRQAEDAGDETPDVDPELLRYLVGRVLSGSAEAEPQPEASAPPPrrlrrSLDQNPPPPVPSEE 229
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....
gi 7019519    235 VLGALLRVKRL------------------ETPAPQVPARRLLPP 260
Cdd:pfam07259 230 VSGALLRVKRLgdleglqrmkridtdlqpETYDPQAPARRLLPY 273
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH